دوره 12، شماره 2 - ( 6-1405 )
|
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mirabi P. From adherence to medication safety: Rethinking self-administered ovarian stimulation in IVF/ICSI care. Caspian J Reprod Med 2026; 12 (2) :1-3
URL: http://caspjrm.ir/article-1-304-fa.html
URL: http://caspjrm.ir/article-1-304-fa.html
From adherence to medication safety: Rethinking self-administered ovarian stimulation in IVF/ICSI care. نشریه طب تولید مثل خزر. 1405; 12 (2) :1-3
: (340 مشاهده)
Infertility affects approximately one in six people worldwide, making medication safety an essential component of high-quality fertility care. During IVF/ICSI, ovarian stimulation is largely managed at home, requiring patients to prepare, dose, store, and administer individualized medications, often following brief instruction. Available evidence suggests that medication-related difficulties may be more common than clinicians recognize, involving dosing, communication, dispensing, and injection device use. Importantly, medication adherence should not be equated with medication safety. A safer approach requires ongoing education, demonstration and teach-back, accessible professional support, and confidential, nonpunitive reporting of medication errors and near misses. Reframing self-administered ovarian stimulation as a system-level medication safety issue may help identify preventable risks, strengthen treatment support, and reduce avoidable disruptions to fertility care.
نوع مطالعه: نامه به سردبیر |
موضوع مقاله:
Reproductive Health
دریافت: 1405/6/13 | پذیرش: 1405/7/6 | انتشار: 1405/7/7
دریافت: 1405/6/13 | پذیرش: 1405/7/6 | انتشار: 1405/7/7
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
